Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Developmental toxicity / teratogenicity

Currently viewing:

Administrative data

Endpoint:
developmental toxicity
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
comparable to guideline study

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1999

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 414 (Prenatal Developmental Toxicity Study)
Version / remarks:
before 27th June 2018
Deviations:
no
GLP compliance:
not specified
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Methacrylic acid
EC Number:
201-204-4
EC Name:
Methacrylic acid
Cas Number:
79-41-4
Molecular formula:
C4H6O2
IUPAC Name:
2-methylprop-2-enoic acid
Test material form:
liquid
Specific details on test material used for the study:
TEST MATERIAL:
- Name of test material: Methacrylic acid
- CAS: 79-41-4
Obtained from Fluka Chemie AG

Test animals

Species:
rat
Strain:
Sprague-Dawley
Details on test animals or test system and environmental conditions:
Nulliparous female Sprague-Dawley rats, weighing 180-200 grams obtained from IFFA Credo Breeding Labs.
Age at Start of Test: sexually mature females; age not specified. Mated females were housed inclear polycarbonate cages with stainless steel wire lids and hardwood shavings for bedding. 
Food and water available adlibitum except during exposures.
12 hours light-dark photocycle
Acclimatization of test animals: 2 weeks

Administration / exposure

Route of administration:
inhalation
Type of inhalation exposure (if applicable):
whole body
Vehicle:
unchanged (no vehicle)
Details on exposure:
Exposures were whole body and conducted in a 200 L chamber. Chamber temperature was 23 °C +/- 2 °C, and the relative humidity was 50% +/- 5%. Food and water were withheld during exposure. Dynamic and adjustable laminar air flow (6 - 20 m³/h). Air was passed through a heated bubbler containing test material. The vaporized material was then introduced into the exposure chambers.
Analytical verification of doses or concentrations:
yes
Details on analytical verification of doses or concentrations:
Concentrations were determined 3 times at regular intervals during each 6 hr exposure by collecting the material and analyzing against a standard using GC.

Target concentrations [ppm] Analytical concentrations [ppm]
mean +/- SD
--------------------------------------------------------------------------------
50 55.3 +/- 8.1
100 101.5 +/-16.9
200 207.3 +/- 24.7
300 316.0 +/- 36.7
--------------------------------------------------------------------------------
Details on mating procedure:
2-3 females were caged with one male rat for mating. The onset of gestation was based upon the presence of sperm in the vaginal smear and this was designated gestation day 0. After confirmation of mating, females were turned to an individual cage. 
Duration of treatment / exposure:
6 hours per day
Frequency of treatment:
day 6 to 20 of gestation
Duration of test:
Mated females were exposed 6 hr/day on days 6 through 20 of gestation.
Doses / concentrationsopen allclose all
Dose / conc.:
50 ppm
Remarks:
corresponds to 179 mg/m3
Dose / conc.:
100 ppm
Remarks:
corresponds to 358 mg/m3
Dose / conc.:
200 ppm
Remarks:
corresponds to 716 mg/m3
Dose / conc.:
300 ppm
Remarks:
corresponds to 1076 mg/m3
No. of animals per sex per dose:
23 to 27 female rats were bred resulting in 22 to 23 pregnant rats used for experiment.
Control animals:
yes, concurrent no treatment

Examinations

Maternal examinations:
BODY WEIGHT: Yes
- Time schedule for examinations: GDs 0, 6, 13 and 21

FOOD CONSUMPTION: Yes
- Time schedule for examinations: GDs 6-13 and 13-21
Ovaries and uterine content:
Uterine content was examined after termination: Yes
Examinations included:
- uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: No data
- Number of viable and dead fetuses: Yes

At necropsy, the uterine horns and ovaries were exposed to count the C.L., implantation sites, resorption sites, and viable and dead fetuses.   FERTILITY AND REPRODUCTIVE PERFORMANCE: The following data were recorded for each group of numbers of CL, and implantation sites o number of resorptions and viable and dead fetuses. O mean fetal body weights o  fetuses examined for gross malformations and skeletal abnormalities of sex and of fetuses.
Fetal examinations:
- External examinations: Yes
- Soft tissue examinations: Yes
- Skeletal examinations: Yes
- Head examinations: No data

Live fetuses were weighed, sexed, and examined for external  anomalies. 50% of the live fetuses from each litter were preserved in Bouin's solution and examined for internal soft-tissue changes. The remaining fetuses (50%) were fixed in ethanol (70%), eviscerated and then processed for skeletal staining with alizarin red S.
Statistics:
The number of corpora lutea, implantation sites, and live fetuses, maternal food consumption and various body weights were analyzed by ANOVA, followed by Dunnett's
test. The percentage of non-live  implant, resorptions, and males and the proportion of fetuses with alterations in each litter were evaluated by Kruskal-Walles test followed by Dixon-Massey test. Rates of pregnancy and percentage of litters with any malformations or external, visceral, or skeletal variations were analyzed using Fisher's test. Where appropriate, least squares analysis was performed. The level of significance was p < 0.05. The litter was used as the basis of analysis of fetal variables.
Indices:
Pre- and postimplantation loss; live birth index

Results and discussion

Results: maternal animals

General toxicity (maternal animals)

Clinical signs:
not specified
Dermal irritation (if dermal study):
not specified
Mortality:
no mortality observed
Description (incidence):
All animals survied the exposure.
Body weight and weight changes:
effects observed, treatment-related
Description (incidence and severity):
Absolute weight gain was significantly reduced at 300 ppm.

Change in weight during gestation in Sprague-Dawley rats inhaling Methacrylic acid on days 6 to 20 of gestation and euthanized on day 21:
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Concentrations No of dams Mean Body weight [g] +/- SD Mean body weight gain on GD [g] Mean absolute weight gain [g]
[ppm], 6 h/day on GD 6 6 - 13 13 - 21 6 - 21
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------
0 23 276 +/- 19 32 +/- 9 109 +/- 32 141 +/- 36 36 +/- 13
50 22 278 +/- 18 32 +/- 8 115 +/- 13 147 +/- 15 35 +/- 11
100 22 283 +/- 19 34 +/- 7 110 +/- 19 144 +/- 23 36 +/- 14
200 22 284 +/- 22 29 +/- 8 107 +/- 20 136 +/- 24 32 +/- 13
300 23 276 +/- 16 20 +/- 7** 91 +/- 26* 111 +/- 29** 12 +/- 14**
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------
*, ** Denote significant differences from the control (0 ppm), p < 0.05 and p < 0.01, respectively.

Mean absolute weight gain: Mean body weight gain corrected by gravid uterine weight
Food consumption and compound intake (if feeding study):
effects observed, treatment-related
Description (incidence and severity):
Food consumption was reduced at 300 ppm.

Food consumption of Sprague-Dawley rats inhaling Methacrylic acid on days 6 to 20 of gestation and euthanized on day 21:
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Concentrations No of dams Mean food consumption [g/dam/day] on GD
[ppm], 6 h/day 6 - 13 13 - 21 6 - 21
------------------------------------------------------------------------------------------------------------------------------------------------------------------------
0 23 23 +/- 2 27 +/- 3 25 +/- 2
50 22 24 +/- 1 28 +/- 2 26 +/- 2
100 22 24 +/- 3 28 +/- 3 26 +/- 3
200 22 22 +/- 2 27 +/- 2 25 +/- 2
300 23 20 +/- 2** 24 +/- 2** 22 +/- 26*
------------------------------------------------------------------------------------------------------------------------------------------------------------------------
*, ** Denote significant differences from the control (0 ppm), p < 0.05 and p < 0.01, respectively.
Food efficiency:
not specified
Water consumption and compound intake (if drinking water study):
not specified
Ophthalmological findings:
not specified
Haematological findings:
not specified
Clinical biochemistry findings:
not specified
Urinalysis findings:
not specified
Behaviour (functional findings):
not specified
Immunological findings:
not specified
Organ weight findings including organ / body weight ratios:
not specified
Gross pathological findings:
not specified
Neuropathological findings:
not specified
Histopathological findings: non-neoplastic:
not specified
Histopathological findings: neoplastic:
not specified

Maternal developmental toxicity

Number of abortions:
no effects observed
Description (incidence and severity):
There were no abortions reported.
Pre- and post-implantation loss:
no effects observed
Description (incidence and severity):
There were no significant changes in number of implantations across control and exposed groups.
Total litter losses by resorption:
no effects observed
Description (incidence and severity):
Total litter loss by resoprtion was not reported.
Early or late resorptions:
no effects observed
Description (incidence and severity):
The number of early and late resorptions was unaffected by treatment.
Dead fetuses:
no effects observed
Description (incidence and severity):
The number of dead fetuses was not reported.
Changes in pregnancy duration:
not specified
Description (incidence and severity):
In the OECD 414, a Caesarian section on GD 21 is performed.
Changes in number of pregnant:
no effects observed
Description (incidence and severity):
The number of pregnant females is comparable to the control.
Details on maternal toxic effects:
Maternal toxic effects: yes

Details on maternal toxic effects:
All animals survived the exposure. Exposure to 300 ppm led to significant decreases in maternal weight gain and food consumption throughout exposure. Absolute weight gain was significantly reduced at 300 ppm.

Effect levels (maternal animals)

Dose descriptor:
NOAEL
Effect level:
200 ppm
Based on:
test mat.
Basis for effect level:
body weight and weight gain
Remarks on result:
other: corresponds to 716 mg/m³

Maternal abnormalities

Abnormalities:
no effects observed

Results (fetuses)

Fetal body weight changes:
no effects observed
Description (incidence and severity):
The fetal body weight was unaffected by treatment.
Reduction in number of live offspring:
no effects observed
Description (incidence and severity):
Reproductive parameters in Sprague-Dawley rats inhaling Methacrylic acid on days 6 to 20 of gestation and euthanized on day 21:
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Concentrations No of litters No. of live fetuses per litter
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
0 22 14.73 +/- 3.92
50 22 14.86 +/- 1.93
100 22 14.05 +/- 3.17
200 22 13.77 +/- 3.99
300 22 14.05 +/- 3.76
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Changes in sex ratio:
no effects observed
Description (incidence and severity):
Reproductive parameters in Sprague-Dawley rats inhaling Methacrylic acid on days 6 to 20 of gestation and euthanized on day 21:
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Concentrations No of litters Average fetal body weight [g/per litter]
[ppm], 6 h/day All Males Females
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
0 22 5.71 +/- 0.56 5.86 +/- 0.57 5.42 +/- 0.37
50 22 5.66 +/- 0.27 5.82 +/- 0.32 5.49 +/- 0.27
100 22 5.79 +/- 0.30 5.92 +/- 0.32 5.62 +/- 0.32
200 22 5.76 +/- 0.47 5.92 +/- 0.47 5.54 +/- 0.45
300 22 5.67 +/- 0.49 5.71 +/- 0.34 5.54 +/- 0.52
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Changes in litter size and weights:
not specified
Description (incidence and severity):
Litter size and weights were not reported.
Changes in postnatal survival:
not specified
Description (incidence and severity):
The pups were euthanised before birth.
External malformations:
no effects observed
Description (incidence and severity):
No significant increase of external fetal malformations was observed after exposure to methacrylic acid. There was no difference between the control and exposed groups.
Description please see attached document (Incidence of malformations and variations in fetuses of Spraque-Dawley rats inhaling Methacrylic acid on days 6 to 20 of gestation).
Skeletal malformations:
no effects observed
Description (incidence and severity):
No significant increase of skeletal fetal malformations was observed after exposure to methacrylic acid. There was no difference between the control and exposed groups.
Description please see attached document (Incidence of malformations and variations in fetuses of Spraque-Dawley rats inhaling Methacrylic acid on days 6 to 20 of gestation).
Visceral malformations:
no effects observed
Description (incidence and severity):
No significant increase of visceral fetal malformations was observed after exposure to methacrylic acid. There was no difference between the control and exposed groups.
Description please see attached document (Incidence of malformations and variations in fetuses of Spraque-Dawley rats inhaling Methacrylic acid on days 6 to 20 of gestation).
Other effects:
not specified
Details on embryotoxic / teratogenic effects:
Embryotoxic / teratogenic effects: no effects

Details on embryotoxic / teratogenic effects:
There were no significant changes in number of implantations and live fetuses, in the incidence of non-live implants and sorptions, or in fetal weights across groups. One fetus of 200 ppm and two of the 300 ppm group showed different types of malfomations. There was no consistent pattern of changes to suggest any treatment-related effects. The difference of fetuses with external, visceral, and skeletal variations did not differ between the control and the treated groups. No significant increase in embryo/fetal lethality or fetal malformations were observed after exposure to methacrylic acid. While maternal toxicity was observed, methacrylic acid caused no evidence of developmental toxicity up to 300 ppm.

Effect levels (fetuses)

Dose descriptor:
NOAEL
Remarks:
prenatal developmental toxicity
Effect level:
> 300 ppm
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: no adverse effects observed

Fetal abnormalities

Abnormalities:
no effects observed

Overall developmental toxicity

Developmental effects observed:
no

Any other information on results incl. tables

Methacylic acid (Saillenfait 1999, OECD 414 rat inhalativ 6 h/day)
control 50 ppm (corresponding
179 mg/m³)
100 ppm (corresponding
358 mg/m³)
200 ppm (corresponding
716 mg/m³)
300 ppm (corresponding
1076 mg/m³)
number of pregnant/ non pregnant dams 25 (total) / 23 (= 92%)
pregnant / 2 non pregnant
25 (total) / 22 (= 88%)
pregnant / 3 non pregnant
26 (total) / 23 (= 84.6%)
pregnant / 3 non pregnant
25 (total) / 22 (= 88%)
pregnant / 3 non pregnant
26 (total) / 23 (= 88.5%)
pregnant / 3 non pregnant
number of dams with abortions/ early deliveries/
stillbirths/ resorptions and/or dead fetuses
number of abortions not explicitly specified early deliveries were not reported (assumed to be 0) number of stillbirth were not reported (assumed to be 0) number of resorptions: 8.96 +/- 20.73 number of abortions not explicitly specified early deliveries were not reported (assumed to be 0) number of stillbirth were not reported (assumed to be 0) number of resorptions: 3.22 +/- 3.34 number of abortions not explicitly specified early deliveries were not reported (assumed to be 0)  number of stillbirth were not reported (assumed to be 0) number of resorptions: 6.76 +/- 8.14 number of abortions not explicitly specified early deliveries were not reported (assumed to be 0) number of stillbirth were not reported (assumed to be 0)  number of resorptions: 5.67+/- 12.77 number of abortions not explicitly specified early deliveries were not reported (assumed to be 0) number of stillbirth were not reported (assumed to be 0) number of resorptions: 10.61 +/- 21.45
pre-implantation loss (as no individual data is given in the publication, the pre-implantation loss is calculated based on the means of number of corpora lutea and number of implantation sites) 12.55 mean 4.6 mean 7.58 mean 12.01 mean 9.81 mean
postimplantation loss (as no individual data is given in the publication, the postimplantation loss is calculated based on the means of number of implantation sites and number of live offspring) 1.21 mean 3.26 mean 6.33 mean 4.11 mean 2.63 mean
Mean Body weight [g] on GD6 276 +/- 19 SD 278 +/- 18 SD 283 +/- 19 SD 284 +/- 22 SD 276 +/- 16 SD
Mean Body weight change [g] 141 +/- 36 on GD 6-21 147 +/- 15 on GD 6-21 144 +/- 23 on GD 6-21 136 +/- 24 on GD 6-21 111 +/- 29** on GD 6-21
significant different from the control (0 ppm)
mean gravid uterine weight including optionally body weight
change corrected for gravid uterine weight (difference between body weight gain from GD 6-21 and absolute body weight gain)
105 g mean  112 g mean   108 g mean  104 g mean 99 g mean
mean number and percent of live offspring 14.73 live pups/litter percentage not specified

14.86 live pups/litter

percentage not specified

14.05 live pups/litter percentage not specified

13.77 live pups/litter

percentage not specified

14.05 live pups/litter

percentage not specified

mean foetal/ pup weight by sex and sexes combined 5.71 mean (g/litter)
5.86 males (g/litter)
5.42 females (g/litter)
5.66 mean (g/litter)
5.82 males (g/litter)
5.49 females (g/litter)
5.79 mean (g/litter)
5.92 males (g/litter)
5.62 females (g/litter)
5.76 mean (g/litter)
5.92 males (g/litter)
5.54 females (g/litter)
5.67 mean (g/litter)
5.71 males (g/litter)
5.54 females (g/litter)
number and percent of foetuses and litters with
malformations (including runts) and/ or variations

number of malformations: -                

litter affected: -

number of variations: 37/324 or 11.4%

litter affected: 21/22 (95.4%)

number of malformations: -                       

litter affected: -

number of variations: 35/327 or 10.7%                       

litter affected: 20/22 (90.9%)

number of

malformations: -                 

litter affected: -

number of variations: 41/309 or 13.3%

litter affected: 15/22 (68.2%)

number of malformations: 1/303 or 0.3%                                       

litter affected: 1/22 or 4.5%             

number of variations: 29/303 or 9.6%

litter affected: 16/22 (72.7%)

number of malformations: 2/309 or 0.6%                                                              

litter affected: 2/22 or 9.0%                                      

number of variations: 39/309 or 12.6%                        

litter affected: 16/22 (72.7%)

description and incidences of malformations and main
variations (and/or retardation)
(detailed information see attached document to the IUCLID entry of this study
(Incidence of malformations and variations in fetuses of Spraque-Dawley rats
 inhaling Methacrylic acid on days 6 to 20 of gestation))
(detailed information see attached document to the IUCLID entry of this study
(Incidence of malformations and variations in fetuses of Spraque-Dawley rats
 inhaling Methacrylic acid on days 6 to 20 of gestation))
(detailed information see attached document to the IUCLID entry of this study
(Incidence of malformations and variations in fetuses of Spraque-Dawley rats
 inhaling Methacrylic acid on days 6 to 20 of gestation))
(detailed information see attached document to the IUCLID entry of this study
(Incidence of malformations and variations in fetuses of Spraque-Dawley rats
 inhaling Methacrylic acid on days 6 to 20 of gestation))
(detailed information see attached document to the IUCLID entry of this study
(Incidence of malformations and variations in fetuses of Spraque-Dawley rats
 inhaling Methacrylic acid on days 6 to 20 of gestation))

Applicant's summary and conclusion

Conclusions:
Using a valid scientific method, no significant increase in embryo/fetal lethality or fetal malformations were observed after exposure to methacrylic acid. While maternal toxicity was observed, methacrylic acid caused no evidence of developmental toxicity up to 300 ppm.
Executive summary:

In an OECD 414 prenatal developmental toxicity study using whole body inhalation methacrylic acid at test concentrations of 50, 100, 200 and 300 ppm, corresponding to 179, 358, 716 and 1076 mg/m³ methacylic acid did not produce any embryo - or foetal lethality, nor fetal malformations, despite overt maternal toxicity (decreased body weight and feed consumption). The NOEC (teratogenicity) was considerd to be 300 ppm (1076 mg/m³).

NOTE: Any of data in this dataset are disseminated by the European Union on a right-to-know basis and this is not a publication in the same sense as a book or an article in a journal. The right of ownership in any part of this information is reserved by the data owner(s). The use of this information for any other, e.g. commercial purpose is strictly reserved to the data owners and those persons or legal entities having paid the respective access fee for the intended purpose.